Loomis Sayles & Co. L P Cuts Position in Huron Consulting Group Inc. $HURN

Loomis Sayles & Co. L P reduced its holdings in shares of Huron Consulting Group Inc. (NASDAQ:HURN) by 2.4% in the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 302,714 shares of the business services provider’s stock after selling 7,299 shares during the period. Loomis Sayles & Co. L P’s holdings in Huron Consulting Group were worth $41,635,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in the business. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in shares of Huron Consulting Group by 149.7% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,199,574 shares of the business services provider’s stock valued at $172,079,000 after acquiring an additional 719,199 shares during the period. Franklin Resources Inc. increased its holdings in Huron Consulting Group by 27.5% in the 2nd quarter. Franklin Resources Inc. now owns 610,908 shares of the business services provider’s stock valued at $84,024,000 after purchasing an additional 131,620 shares in the last quarter. Jennison Associates LLC increased its holdings in Huron Consulting Group by 17.4% in the 2nd quarter. Jennison Associates LLC now owns 581,397 shares of the business services provider’s stock valued at $79,965,000 after purchasing an additional 86,069 shares in the last quarter. Invesco Ltd. raised its position in Huron Consulting Group by 7.9% in the first quarter. Invesco Ltd. now owns 282,017 shares of the business services provider’s stock valued at $40,455,000 after purchasing an additional 20,680 shares during the period. Finally, Neumeier Poma Investment Counsel LLC lifted its stake in shares of Huron Consulting Group by 11.7% during the second quarter. Neumeier Poma Investment Counsel LLC now owns 272,845 shares of the business services provider’s stock worth $37,527,000 after purchasing an additional 28,527 shares in the last quarter. Institutional investors and hedge funds own 93.90% of the company’s stock.

Insiders Place Their Bets

In other news, Director John Mccartney sold 6,500 shares of the business’s stock in a transaction dated Wednesday, November 19th. The shares were sold at an average price of $161.44, for a total value of $1,049,360.00. Following the completion of the sale, the director owned 43,317 shares of the company’s stock, valued at approximately $6,993,096.48. The trade was a 13.05% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, COO James Ronald Dail sold 7,824 shares of the company’s stock in a transaction dated Wednesday, October 29th. The shares were sold at an average price of $169.53, for a total transaction of $1,326,402.72. Following the completion of the sale, the chief operating officer owned 31,184 shares in the company, valued at approximately $5,286,623.52. This trade represents a 20.06% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 24,308 shares of company stock valued at $3,872,885 in the last ninety days. Corporate insiders own 2.15% of the company’s stock.

Analyst Ratings Changes

HURN has been the subject of a number of recent research reports. Benchmark increased their target price on Huron Consulting Group from $165.00 to $180.00 and gave the company a “buy” rating in a research note on Monday, October 27th. Wall Street Zen upgraded Huron Consulting Group from a “hold” rating to a “buy” rating in a report on Saturday, November 1st. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Huron Consulting Group in a research report on Wednesday, October 8th. Truist Financial lifted their price objective on shares of Huron Consulting Group from $180.00 to $240.00 and gave the company a “buy” rating in a research note on Friday, November 14th. Finally, Barrington Research upped their target price on shares of Huron Consulting Group from $173.00 to $176.00 and gave the company an “outperform” rating in a research note on Thursday, August 7th. Six investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the stock has an average rating of “Buy” and a consensus target price of $190.25.

Huron Consulting Group Trading Down 0.2%

Shares of HURN opened at $164.61 on Friday. Huron Consulting Group Inc. has a one year low of $118.25 and a one year high of $174.26. The stock has a 50-day moving average price of $156.00 and a 200 day moving average price of $144.12. The company has a debt-to-equity ratio of 1.18, a quick ratio of 1.99 and a current ratio of 1.44. The company has a market capitalization of $2.84 billion, a P/E ratio of 27.57 and a beta of 0.28.

Huron Consulting Group (NASDAQ:HURN) last announced its earnings results on Tuesday, October 28th. The business services provider reported $2.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.86 by $0.24. The company had revenue of $441.28 million for the quarter, compared to analyst estimates of $418.13 million. Huron Consulting Group had a return on equity of 27.06% and a net margin of 6.54%.Huron Consulting Group’s quarterly revenue was up 16.7% on a year-over-year basis. During the same period in the prior year, the company posted $1.68 EPS. Huron Consulting Group has set its FY 2025 guidance at 7.600-7.700 EPS. Sell-side analysts forecast that Huron Consulting Group Inc. will post 6.1 EPS for the current fiscal year.

About Huron Consulting Group

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children’s and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.